Design Therapeutics Inc

NASDAQ:DSGN   9:45:51 AM EDT
15.63
-0.11 (-0.70%)
Earnings Announcements

Design Therapeutics Reports Pipeline Progress And Third Quarter 2021 Results

Published: 11/09/2021 22:08 GMT
Design Therapeutics Inc (DSGN) - Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results.
Design Therapeutics Inc Qtrly Loss per Share $0.21.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.